These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33871785)

  • 21. The effects of cognitive remediation therapy using the frontal/executive program for autism spectrum disorder.
    Miyajima M; Omiya H; Yamashita K; Miyata T; Yambe K; Matsui M; Denda K
    Int J Psychiatry Med; 2016 Apr; 51(3):223-35. PubMed ID: 27284115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive boosting interventions for impulsivity in addiction: a systematic review and meta-analysis of cognitive training, remediation and pharmacological enhancement.
    Anderson AC; Youssef GJ; Robinson AH; Lubman DI; Verdejo-Garcia A
    Addiction; 2021 Dec; 116(12):3304-3319. PubMed ID: 33751683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Randomized Controlled Trial of Executive Functioning Training Compared With Perceptual Training for Schizophrenia Spectrum Disorders: Effects on Neurophysiology, Neurocognition, and Functioning.
    Best MW; Milanovic M; Iftene F; Bowie CR
    Am J Psychiatry; 2019 Apr; 176(4):297-306. PubMed ID: 30845819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorder.
    Macoveanu J; Demant KM; Vinberg M; Siebner HR; Kessing LV; Miskowiak KW
    J Psychopharmacol; 2018 Oct; 32(10):1075-1085. PubMed ID: 29969938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive enhancement interventions for people with bipolar disorder: A systematic review of methodological quality, treatment approaches, and outcomes.
    Tsapekos D; Seccomandi B; Mantingh T; Cella M; Wykes T; Young AH
    Bipolar Disord; 2020 May; 22(3):216-230. PubMed ID: 31610086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of cognitive rehabilitation using computer software with individuals living with schizophrenia: A randomized controlled trial in Japan.
    Iwata K; Matsuda Y; Sato S; Furukawa S; Watanabe Y; Hatsuse N; Ikebuchi E
    Psychiatr Rehabil J; 2017 Mar; 40(1):4-11. PubMed ID: 28182471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility and effectiveness of cognitive remediation in the treatment of borderline personality disorder.
    Vita A; Deste G; Barlati S; Poli R; Cacciani P; De Peri L; Sacchetti E
    Neuropsychol Rehabil; 2018 Apr; 28(3):416-428. PubMed ID: 26872501
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility and effectiveness of a cognitive remediation programme with original computerised cognitive training and group intervention for schizophrenia: a multicentre randomised trial.
    Matsuda Y; Morimoto T; Furukawa S; Sato S; Hatsuse N; Iwata K; Kimura M; Kishimoto T; Ikebuchi E
    Neuropsychol Rehabil; 2018 Apr; 28(3):387-397. PubMed ID: 27150346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder.
    McClure MM; Graff F; Triebwasser J; Perez-Rodriguez M; Rosell DR; Koenigsberg H; Hazlett EA; Siever LJ; Harvey PD; New AS
    Am J Psychiatry; 2019 Apr; 176(4):307-314. PubMed ID: 30654644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of factors that influence the efficacy of cognitive remediation therapy in schizophrenia.
    Reser MP; Slikboer R; Rossell SL
    Aust N Z J Psychiatry; 2019 Jul; 53(7):624-641. PubMed ID: 31177813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive Remediation Interventions in Autism Spectrum Condition: A Systematic Review.
    Dandil Y; Smith K; Kinnaird E; Toloza C; Tchanturia K
    Front Psychiatry; 2020; 11():722. PubMed ID: 32793009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroplastic and cognitive impairment in substance use disorders: a therapeutic potential of cognitive stimulation.
    Sampedro-Piquero P; Ladrón de Guevara-Miranda D; Pavón FJ; Serrano A; Suárez J; Rodríguez de Fonseca F; Santín LJ; Castilla-Ortega E
    Neurosci Biobehav Rev; 2019 Nov; 106():23-48. PubMed ID: 30481530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cognitive remediation and cognitive assistive technologies in schizophrenia].
    Sablier J; Stip E; Franck N
    Encephale; 2009 Apr; 35(2):160-7. PubMed ID: 19393385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive Training Effectiveness on Memory, Executive Functioning, and Processing Speed in Individuals With Substance Use Disorders: A Systematic Review.
    Caetano T; Pinho MS; Ramadas E; Clara C; Areosa T; Dixe MDA
    Front Psychol; 2021; 12():730165. PubMed ID: 34489833
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurocognitive Empowerment for Addiction Treatment (NEAT): study protocol for a randomized controlled trial.
    Ekhtiari H; Rezapour T; Sawyer B; Yeh HW; Kuplicki R; Tarrasch M; Paulus MP; Aupperle R
    Trials; 2021 May; 22(1):330. PubMed ID: 33962675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of cognitive remediation on cognitive and social functions in individuals with schizophrenia.
    Katsumi A; Hoshino H; Fujimoto S; Yabe H; Ikebuchi E; Nakagome K; Niwa SI
    Neuropsychol Rehabil; 2019 Oct; 29(9):1475-1487. PubMed ID: 29212415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated cognitive remediation and standard rehabilitation therapy in patients of schizophrenia: persistence after 5years.
    Buonocore M; Spangaro M; Bechi M; Baraldi MA; Cocchi F; Guglielmino C; Bianchi L; Mastromatteo A; Bosia M; Cavallaro R
    Schizophr Res; 2018 Feb; 192():335-339. PubMed ID: 28545942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cognitive Remediation in Bipolar (CRiB) pilot study: study protocol for a randomised controlled trial.
    Strawbridge R; Fish J; Halari R; Hodsoll J; Reeder C; Macritchie K; McCrone P; Wykes T; Young AH
    Trials; 2016 Jul; 17():371. PubMed ID: 27472964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive remediation plus standard treatment versus standard treatment alone for individuals at ultra-high risk of developing psychosis: Results of the FOCUS randomised clinical trial.
    Glenthøj LB; Mariegaard LS; Fagerlund B; Jepsen JRM; Kristensen TD; Wenneberg C; Krakauer K; Medalia A; Roberts DL; Hjorthøj C; Nordentoft M
    Schizophr Res; 2020 Oct; 224():151-158. PubMed ID: 32873460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of caregiver-provided individual cognitive interventions on cognition, social functioning and quality of life in older adults with major neurocognitive disorders: a systematic review.
    Silva R; Bobrowicz-Campos E; Cardoso D; Costa P; Couto F; Camarneiro AP; Abrunheiro S; Almeida M; Apóstolo J
    JBI Evid Synth; 2020 Apr; 18(4):743-806. PubMed ID: 32813340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.